In IL-17-dominant skin disorders such as psoriasis, Th17.1/exTh17 are present, although less pronounced compared to IFN-γ-dominant skin disorders, and their inhibition seems not essential as demonstrated by the high efficacy of IL-17 inhibitors. The gene discussed is IFNG; the disease is psoriasis.